Biocompatible disulphide cross-linked sodium alginate derivative nanoparticles for oral colon-targeted drug delivery
Source abstract
Abstract
The application of layer-by-layer (LbL) approach on nanoparticle surface coating improves the colon-specific drug delivery of insoluble drugs. Here, we aimed to formulate a self-assembled cysteamine-based disulphide cross-linked sodium alginate with LbL self-assembly to improve the delivery of paclitaxel (PCX) to colonic cancer cells. Cysteamine was conjugated to the backbone of oxidized SA to form a core of self-assembled disulphide cross-linked nanospheres. P3DL was selected for PCX loading and fabricated LbL with poly(allylamine hydrochloride) (PAH) and poly(4-styrenesulfonic acid-co-maleic acid) sodium salt (PSSCMA) resulting from characterization and drug release studies. P3DL-fabricated PCX-loaded nanospheres (P3DL/PAH/PSSCMA) exhibited an encapsulation efficiency of 77.1% with cumulative drug release of 45.1%. Dynamic light scattering analysis was reported at 173.6 ± 2.5 nm with polydispersity index of 0.394 ± 0.105 (zeta potential= -58.5 mV). P3DL/PAH/PSSCMA demonstrated a pH-dependent swelling transition; from pH 1 to 7 (102.2% increase). The size increased by 33.0% in reduction response study after incubating with 10 mM glutathione (day 7). HT-29 cells showed high viabilities (86.7%) after treatment with the fabricated nanospheres at 0.8 µg/mL. Cellular internalization was successful with more than 70.0% nanospheres detected in HT-29 cells. Therefore, this fabricated nanospheres may be considered as potential nanocarriers for colon cancer-targeted chemotherapeutic drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Biomedical Research and Pathophysiology · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Integrative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia
Department of Chemical Engineering Technology, Faculty of Engineering Technology, Universiti Malaysia Perlis
Regenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia
Funding
Universiti Sains Malaysia · Ministry of Education · Error! Hyperlink reference not valid. · Bridging Grant, USM · Fundamental Research Grant Scheme
References (49)
Show source-provided references
1. Sreelatha D, Brahma C. Colon targeted drug delivery – a review on primary and novel approaches. J Glob Trends Pharm. 2013;4:1174–1183.
2. 10.1021/jm301381a10.1021/jm301381a ↗
3. 10.1155/2014/92427810.1155/2014/924278 ↗
4. 10.1016/j.ejpb.2015.10.01010.1016/j.ejpb.2015.10.010 ↗
5. 10.1155/2014/92615710.1155/2014/926157 ↗
6. 10.1016/j.carbpol.2012.01.02010.1016/j.carbpol.2012.01.020 ↗
7. 10.1016/j.msec.2014.10.00310.1016/j.msec.2014.10.003 ↗
8. 10.5138/ijdd.2010.0975.0215.0200610.5138/ijdd.2010.0975.0215.02006 ↗
9. Yusuf SNAM, Ng YM, Ayub AD, et al. Characterisation and evaluation of trimesic acid derivatives as disulphide cross-linked polymers for potential colon targeted drug delivery. Polymers 2017;9:1–16.
10. 10.1016/j.ijbiomac.2014.12.05210.1016/j.ijbiomac.2014.12.052 ↗
11. 10.1016/j.carbpol.2014.05.01210.1016/j.carbpol.2014.05.012 ↗
12. 10.1039/C6TB03032G10.1039/C6TB03032G ↗
13. 10.1002/jbm.a.3405110.1002/jbm.a.34051 ↗
14. 10.1016/j.cis.2014.03.00910.1016/j.cis.2014.03.009 ↗
15. 10.1016/j.msec.2012.05.02410.1016/j.msec.2012.05.024 ↗
16. 10.1016/j.carbpol.2015.01.04910.1016/j.carbpol.2015.01.049 ↗
17. 10.1016/j.ijpharm.2010.08.02310.1016/j.ijpharm.2010.08.023 ↗
18. 10.3390/ijms14122467010.3390/ijms141224670 ↗
19. 10.1016/j.colsurfb.2016.03.06410.1016/j.colsurfb.2016.03.064 ↗
20. 10.1016/j.carbpol.2006.05.02510.1016/j.carbpol.2006.05.025 ↗
21. 10.1023/A:101586610405510.1023/A:1015866104055 ↗
22. 10.1016/S0378-5173(03)00271-010.1016/S0378-5173(03)00271-0 ↗
23. Lau Y, Lim V. Colon targeted drug delivery of branch ‑ chained disulphide cross‑linked polymers: design, synthesis, and characterisation studies. Chem Cent J. 2016;10:1–19.
24. 10.1016/j.colsurfb.2012.11.03110.1016/j.colsurfb.2012.11.031 ↗
25. 10.1021/bm200681m10.1021/bm200681m ↗
26. 10.1016/j.carbpol.2014.12.08410.1016/j.carbpol.2014.12.084 ↗
27. 10.1016/j.carbpol.2015.10.01210.1016/j.carbpol.2015.10.012 ↗
28. 10.1016/j.ijpharm.2012.07.04510.1016/j.ijpharm.2012.07.045 ↗
29. Zheng S, Xie Y, Li Y, et al. Development of high drug-loading nanomicelles targeting steroids to the brain. Int J Nanomed. 2013;9:55–66.
30. 10.1039/C6RA02674E10.1039/C6RA02674E ↗
31. Latifi AM, Nejad ES, Babavalian H. Comparison of extraction different methods of sodium alginate from brown alga Sargassum sp. localized in the southern of Iran. J Appl Biotechnol Rep. 2015;2:251–255.
32. 10.1016/j.carbpol.2011.03.03410.1016/j.carbpol.2011.03.034 ↗
33. 10.1016/j.ijpharm.2013.08.03210.1016/j.ijpharm.2013.08.032 ↗
34. 10.1039/C6PY01872F10.1039/C6PY01872F ↗
35. 10.1021/nl502044x10.1021/nl502044x ↗
36. 10.1021/la501047m10.1021/la501047m ↗
37. 10.1016/j.ijpharm.2014.12.05810.1016/j.ijpharm.2014.12.058 ↗
38. 10.1021/cm203245910.1021/cm2032459 ↗
39. 10.1016/j.cis.2017.04.00910.1016/j.cis.2017.04.009 ↗
40. 10.1016/j.addr.2011.03.01610.1016/j.addr.2011.03.016 ↗
41. Niraj, Srivastava VK, Singh N, et al. Sustained and controlled drug delivery system - as a part of modified release dosage form. Int J Pharma Sci. 2013;2:586–601.
42. 10.1002/adma.20150266010.1002/adma.201502660 ↗
43. Han U, Seo Y, Hong J. Effect of pH on the structure and drug release profiles of layer-by- layer assembled films containing polyelectrolyte, micelles, and graphene oxide. Nat Publ Gr 2016;6:24158–24168.
44. 10.1002/jps.2121410.1002/jps.21214 ↗
45. 10.1016/j.jconrel.2015.07.03310.1016/j.jconrel.2015.07.033 ↗
46. 10.1016/j.ijpharm.2011.04.02610.1016/j.ijpharm.2011.04.026 ↗
47. 10.1021/nn901392m10.1021/nn901392m ↗
48. 10.1016/j.ijpharm.2012.07.05910.1016/j.ijpharm.2012.07.059 ↗
49. 10.1088/2043-6262/7/2/02500110.1088/2043-6262/7/2/025001 ↗